Publication:
Does obesity affect treatment response to secukinumab and its survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry

Simple item page
dc.contributor.authorDİRESKENELİ, RAFİ HANER
dc.contributor.authorsKarakaş A., Gulle S., Can G., Dalkılıc E., Akar S., Koca S. S., Pehlivan Y., Senel S., Tufan A., Ozturk M. A., et al.
dc.date.accessioned2023-08-29T12:08:56Z
dc.date.accessioned2026-01-11T17:18:29Z
dc.date.available2023-08-29T12:08:56Z
dc.date.issued2023-06-22
dc.identifier.citationKarakaş A., Gulle S., Can G., Dalkılıc E., Akar S., Koca S. S., Pehlivan Y., Senel S., Tufan A., Ozturk M. A., et al., "Does obesity affect treatment response to secukinumab and its survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry.", Modern rheumatology, 2023
dc.identifier.doi10.1093/mr/road061
dc.identifier.issn1439-7595
dc.identifier.urihttps://hdl.handle.net/11424/292926
dc.language.isoeng
dc.relation.ispartofModern rheumatology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleDoes obesity affect treatment response to secukinumab and its survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry
dc.typearticle
dspace.entity.typePublication

Files

Collections

Araştırma Çıktıları